Ö. G. SEVİNDİK Et Al. , "Real-world data in relapsed refractory myeloma patients with carfilzomib, a multicenter turkish experience," 6th International Congress on Leukemia-Lymphoma-Myeloma , 2017
SEVİNDİK, Ö. G. Et Al. 2017. Real-world data in relapsed refractory myeloma patients with carfilzomib, a multicenter turkish experience. 6th International Congress on Leukemia-Lymphoma-Myeloma .
SEVİNDİK, Ö. G., medeni solmaz, ş., PEHLİVAN, M., HACIOĞLU, S., YALNIZ, F. F., ÖZKOCAMAN, V., ... ARAT, M.(2017). Real-world data in relapsed refractory myeloma patients with carfilzomib, a multicenter turkish experience . 6th International Congress on Leukemia-Lymphoma-Myeloma
SEVİNDİK, ÖMÜR Et Al. "Real-world data in relapsed refractory myeloma patients with carfilzomib, a multicenter turkish experience," 6th International Congress on Leukemia-Lymphoma-Myeloma, 2017
SEVİNDİK, ÖMÜR G. Et Al. "Real-world data in relapsed refractory myeloma patients with carfilzomib, a multicenter turkish experience." 6th International Congress on Leukemia-Lymphoma-Myeloma , 2017
SEVİNDİK, Ö. G. Et Al. (2017) . "Real-world data in relapsed refractory myeloma patients with carfilzomib, a multicenter turkish experience." 6th International Congress on Leukemia-Lymphoma-Myeloma .
@conferencepaper{conferencepaper, author={ÖMÜR GÖKMEN SEVİNDİK Et Al. }, title={Real-world data in relapsed refractory myeloma patients with carfilzomib, a multicenter turkish experience}, congress name={6th International Congress on Leukemia-Lymphoma-Myeloma}, city={}, country={}, year={2017}}